MODIFICATION AGREEMENTModification Agreement • January 7th, 2009 • Stem Cell Innovations, Inc. • Biological products, (no disgnostic substances) • New York
This Modification Agreement (“Agreement”) dated as of December , 2008 is entered into by and among Stem Cell Innovations Inc., a Delaware corporation (the “Company”), the noteholders identified on the signature page hereto (each a “Lender” and collectively “Lenders”) and Alpha Capital Anstalt as “Lender” and as a secured Lender (“Alpha”).
SECURED NOTEStem Cell Innovations, Inc. • January 7th, 2009 • Biological products, (no disgnostic substances) • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder of promissory notes dated of even date herewith (the “Subscription Agreement”). Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
SUBSCRIPTION AGREEMENTSubscription Agreement • January 7th, 2009 • Stem Cell Innovations, Inc. • Biological products, (no disgnostic substances) • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), is dated as of December , 2008, by and among Stem Cell Innovations, Inc., a Delaware corporation (the “Company”), and Alpha Capital Anstalt (“Subscriber”).
